Cart
sales@molnova.com
CBP/EP300-IN-1
CAS No. 2443789-32-8
CBP/EP300-IN-1( —— )
Catalog No. M28557 CAS No. 2443789-32-8
CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 102 | In Stock |
|
| 2MG | 56 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 264 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 518 | In Stock |
|
| 200MG | 705 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCBP/EP300-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
-
DescriptionCBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorRARα|RARβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2443789-32-8
-
Formula Weight426.44
-
Molecular FormulaC23H23FN2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (146.56 mM)
-
SMILESCC(N1C2=CC=C(OC)C=C2C(C(NC3=C(F)C=CC(C(OC(C)(C)C)=O)=C3)=O)=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jetten AM, et al. New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Cancer Res. 1987 Jul 1;47(13):3523-7.
molnova catalog
related products
-
NEO2734
NEO2734 is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains).
-
dBRD9 HCl
dBRD9 HCl is a PROTAC composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide . dBRD9 HCl is a potent and selective degrader of BRD9 (IC50 = 56.6 nM in MOLM-13 cells).
-
3-methyl-1,2-dihydro...
3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
